Last reviewed · How we verify

Chromium Cr 51 Edetate — Competitive Intelligence Brief

Chromium Cr 51 Edetate (chromium (51Cr) edetate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: chromium (51Cr) edetate. Area: Other.

unknown chromium (51Cr) edetate Other Live · refreshed every 30 min

Target snapshot

Chromium Cr 51 Edetate (chromium (51Cr) edetate). Chromium (51Cr) edetate is a radiopharmaceutical that works by emitting radiation to diagnose or treat certain medical conditions.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Chromium Cr 51 Edetate TARGET chromium (51Cr) edetate unknown chromium (51Cr) edetate

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (chromium (51Cr) edetate class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Chromium Cr 51 Edetate — Competitive Intelligence Brief. https://druglandscape.com/ci/chromium-51cr-edetate. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing